Literature DB >> 2656157

Human ketone body production and utilization studied using tracer techniques: regulation by free fatty acids, insulin, catecholamines, and thyroid hormones.

U Keller1, M Lustenberger, J Müller-Brand, P P Gerber, W Stauffacher.   

Abstract

Ketone body concentrations fluctuate markedly during physiological and pathological conditions. Tracer techniques have been developed in recent years to study production, utilization, and the metabolic clearance rate of ketone bodies. This review describes data on the roles of insulin, catecholamines, and thyroid hormones in the regulation of ketone body kinetics. The data indicate that insulin lowers ketone body concentrations by three independent mechanisms: first, it inhibits lipolysis, and thus lowers free fatty acid availability for ketogenesis; second, it restrains ketone body production within the liver; third, it enhances peripheral ketone body utilization. To assess these effects in humans in vivo, experimental models were developed to study insulin effects with controlled concentrations of free fatty acids, insulin, glucagon, and ketone bodies. Presently available data also support an important role of catecholamines in increasing ketone body concentrations. Evidence was presented that norepinephrine increases ketogenesis not only by stimulating lipolysis, and thus releasing free fatty acids, but also by increasing intrahepatic ketogenesis. Thyroid hormone availability was associated with lipolysis and ketogenesis. Ketone body concentrations after an overnight fast were only modestly elevated in hyperthyroidism resulting from increased peripheral ketone body clearance. There was a significant correlation between serum triiodothyronine levels and the ketone body metabolic clearance rate. Thus, ketone body homeostasis in human subjects resulted from the interaction of hormones such as insulin, catecholamines, and thyroid hormones regulating lipolysis, intrahepatic ketogenesis, and peripheral ketone body utilization.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656157     DOI: 10.1002/dmr.5610050306

Source DB:  PubMed          Journal:  Diabetes Metab Rev        ISSN: 0742-4221


  7 in total

Review 1.  Exogenous Ketone Supplements in Athletic Contexts: Past, Present, and Future.

Authors:  Mark Evans; Tyler S McClure; Andrew P Koutnik; Brendan Egan
Journal:  Sports Med       Date:  2022-10-10       Impact factor: 11.928

Review 2.  Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease.

Authors:  Raja Gopal Reddy Mooli; Sadeesh K Ramakrishnan
Journal:  Front Physiol       Date:  2022-07-04       Impact factor: 4.755

Review 3.  Regulation of Ketone Body Metabolism and the Role of PPARα.

Authors:  Maja Grabacka; Malgorzata Pierzchalska; Matthew Dean; Krzysztof Reiss
Journal:  Int J Mol Sci       Date:  2016-12-13       Impact factor: 5.923

Review 4.  Effect of Elevated Ketone Body on Maternal and Infant Outcome of Pregnant Women with Abnormal Glucose Metabolism During Pregnancy.

Authors:  Meichen Qian; Na Wu; Ling Li; Wenshu Yu; Hong Ouyang; Xinyan Liu; Yujing He; Abdulrahman Al-Mureish
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-25       Impact factor: 3.168

5.  The Effect of Acute Intermittent and Continuous Hypoxia on Plasma Circulating ßOHB Levels Under Different Feeding Statuses in Humans.

Authors:  Caroline Marcoux; Renée Morin; Jean-François Mauger; Pascal Imbeault
Journal:  Front Physiol       Date:  2022-07-06       Impact factor: 4.755

6.  Diabetic ketoacidosis after the treatment of anaphylaxis.

Authors:  Daniel S Brenner; Keith Kleinman; Amy Manzo; Melania M Bembea; David W Cooke
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2022-08-01

7.  SGLT2 Inhibitors and Ketone Metabolism in Heart Failure.

Authors:  Huitzilihuitl Saucedo-Orozco; Suzanne N Voorrips; Salva R Yurista; Rudolf A de Boer; B Daan Westenbrink
Journal:  J Lipid Atheroscler       Date:  2022-01-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.